Interferons (IFNs) can exert cytostatic and immunomodulatory eects on carcinoma cells. In particular, growth inhibition of human prostate carcinoma by IFNs has been demonstrated both in vitro and in vivo. p202 is a 52 kd nuclear phosphoprotein known to be induced by IFNs. In this report, we showed that the expression of p202 was associated with an anti-proliferative eect on human prostate cancer cells. More importantly, cells that expressed p202 showed reduced ability to grow in softagar, indicating a loss of transformation phenotype. Our data suggest that p202 is a growth inhibitor gene in prostate cancer cells and its expression may also suppress transformation phenotype of prostate cancer cells.
Introduction
In American men, prostate carcinoma is the most frequently diagnosed malignancy and is the second leading cause of cancer death after lung cancer. It has been estimated about 209 900 men in the US. will be diagnosed with prostate cancer each year; 41 800 will die of the disease (Von Eschenbach et al., 1997) . The use of cytokines, e.g. interferons (IFNs), as immunotherapeutic agents has been demonstrated in several types of human cancers (Carreno and Mora, 1987; Figlin et al., 1993; Fraker and Alexander, 1994; Rosenberg et al., 1988) . Three major de®ned groups of IFNs are IFN-a, IFN-b and IFN-g (Pestka et al., 1987) . IFN-a is a group of closely related proteins with approximately 75% homology in their amino acid sequences. They are produced upon exposure to viruses, bacteria, and double-stranded RNA and they share the same cell membrane receptor with IFN-b (Balkwill, 1989) . In vitro studies with the hormonerefractory human prostate cancer cell lines showed a direct anti-proliferative eect by IFN-a (Fidler, et al., 1987; Sica et al., 1989; Sokolo et al., 1996) . Although this anti-proliferative eect of IFNs on prostate cancer cells has been recognized, the mechanism of this growth inhibition remains unclear. Moreover, an antitumor function of IFN-a was demonstrated in the treatment of human prostate cancer-nude mice xenografts (van Moorselaar et al., 1991) .
Mouse p202 gene is encoded by one of the six or more structurally related IFN-a-inducible genes of the gene 200 cluster Sen and Lengyel, 1992) . Other family members include p203, p204, and D3 proteins. To date, three human homologs in this family, MNDA (Dawson et al., 1995) , IFI16 (Trapani et al., 1994) , and AIM2 (De Young et al., 1997) have been identi®ed. But the human counterpart of the murine p202 has not been reported. p202 is primarily a nuclear 52 kd phosphoprotein whose expression can be induced 15 ± 20-fold by IFN-a in cultured cells (Choubey and Lengyel, 1993) . p202 has ability to bind to both double-and single-stranded DNA nonspeci®cally in vitro (Choubey and Gutterman, 1996b) . Recently, the functional signi®cance of p202 has been implicated in that p202 can interact with several important cell-cycle, signal transduction, and dierentiation regulatory molecules such as retinoblastoma gene (RB) , E2F-1 (Choubey et al., 1996a) , E2F-4, p107 and p130 (Choubey and Gutterman, 1997) , fos/jun (AP-1), NFkB (Min et al., 1996) , a p53 binding protein (53BP-1) (Datta et al., 1996) , MyoD and myogenin (Datta et al., 1998) . These interactions may be responsible for the subsequent transcriptional inhibition of the genes whose transcriptional activation depend on these molecules (Choubey et al., 1996a; Choubey and Gutterman 1997; Datta et al., 1996 Datta et al., , 1998 Min et al., 1996) . One of the most pronounced cellular consequences resulted by p202 expression has been the cell growth retardation as shown in the transfected cloned murine embryo cells (AKR-2B) and murine connective tissue cells (L929) (Choubey and Lengyel, 1993; Choubey et al., 1996a; Min et al., 1996) . Furthermore, the constitutively expressed p202 inhibits G0/G1-phase progression into the S phase in NIH3T3 cells when the growth arrested cells were stimulated to proliferate (Lembo et al., 1995) . That observation was supported by the recent ®ndings that the expression of another gene 200 cluster family member, p204, also inhibited cell growth in some mouse cultured fibroblasts by accumulating the p204-expressing cells at the G1/S-phase boundary of the cell cycle (Lembo et al., 1998; Lengyel et al., 1995) . However, it is not known whether p202 may also inhibit human cancer cell growth and whether p202 has the ability to suppress transformation phenotype of human cancer cells.
In light of the correlation between the therapeutic eect of IFNs on prostate cancer cells and the growth inhibitory function of the IFN-inducible gene, p202, we tested the hypothesis that an IFN-like anti-proliferative and anti-transformation eects on prostate cancer cells could be achieved by expressing p202 in these cells. In this report, we showed that p202 expression not only could decrease the growth rate but, more importantly, could reduce the ability of a human hormone refractory prostate cancer cell line, PC-3, to grow in an anchorage-independent manner, indicating a loss of transformation phenotype.
Results and discussion
The p202 expression can inhibit human prostate cancer cell growth
Since the IFN-a treatment has been shown to have an anti-proliferative eect on human hormone-refractory prostate cancer cell lines such as PC-3 and DU145 (Fidler et al., 1987; Sica et al., 1989; Sokolo et al., 1996) , we ®rst tested if the expression of the IFN-ainducible protein, p202, was sucient to mediate a growth inhibitory eect on these two human prostate cancer cell lines. A p202 cDNA expression plasmid (CMV-p202) (Choubey et al., 1996a) was transfected into PC-3 and DU145. After 3 weeks of G418 selection, the drug-resistant colonies were scored by crystal violet staining. A dramatic reduction, i.e. more than 90% reduction (Table 1) , in the number of G418-resistant colonies was observed in both cell lines transfected with CMV-p202 (p202) as compared to the pcDNA3 vector control ( Figure 1A ). It is possible that the reduction of colony numbers in p202-transfected prostate cancer cells may be caused by the p202-mediated growth retardation and/or apoptosis. To examine these possible mechanisms and to characterize the function of p202, we attempted to isolate the p202-expressing stable cell lines. For PC-3, out of twenty randomly selected p202-transfected clones, we identi®ed four clones that express p202 protein by western blot with a polyclonal antibody against p202 (Choubey and Lengyel, 1993) : a modest expressor, p202-1, and three high expressors, p202-2, -3 and -4 (Table 1 and Figure 1B ). The control cell lines, PC-3, and the pooled PC-3 colonies transfected with pcDNA3 vector (pcDNA3-pooled), have no detectable endogenous level of p202 protein. As expected, the p202-pooled showed little but detectable p202 protein expression. The positive and negative controls shown in Figure 1B were lysates isolated from AKR-2B cells treated with (+) or without (7) IFN-a, respectively (Choubey and Lengyel, 1993) . It has been previously shown that the p202 antibody also recognizes a 68 kd nonspeci®c protein which can be used as an internal control for normalizing the sample loading (Choubey and Lengyel, 1993) . We have also attempted to isolated the p202-expressing DU145 clones. However, out of 20 G418-resistant colonies screened, none expressed p202 protein (Table 1) . It is possible that DU145 cells may be more sensitive to the p202 expression than PC-3 cells since DU145 cells were more sensitive to the IFN-a-induced growth inhibition than PC-3 cells (Sokolo et al., 1996) . To examine the growth inhibitory function of p202 in prostate cancer cells, we compared the growth rates of Table 1 p202-expressing colonies identi®ed by Western blot using p202 antibody Figure 1 (A) p202 inhibits colony formation of PC-3 and DU145 cells. Both cell lines were transfected with either the vector (pcDNA3) or CMV-p202 (p202) followed by G418 selection. The G418-resistant colonies were visualized by crystal violet staining. (B) Western blot analysis of the p202-expressing PC-3 stable transfectants. The p202 protein (52 kd), as indicated by an arrow, was detected in four clones: a modest expressor, p202-1, and three high expressors, p202-2, -3 and -4. The parental, PC-3, and the vector control, i.e. a pooled G418-resistant colonies transfected with vector (pcDNA3-pooled), do not have detectable endogenous p202 protein expression. A pooled G418-resistant colonies transfected with CMV-p202 (p202-pooled) has little but detectable level of p202 protein. The p202 protein controls are the lysates isolated from AKR-2B cells treated with (+) or without (7) IFN-a. The p202 antibody could cross-react to a 68 kd nonspeci®c protein which migrates just above 67 kd molecular weight marker. The Western blot of pcDNA3-pooled and p202-4 was done on a dierent gel p202-mediated growth arrest and suppression of transformation phototype D-H Yan et al the p202-expressing PC-3 cells with that of the control cells. Figure 2A shows that the high expressors, p202-2, -3 and -4 have a signi®cantly slower growth rate than that of the controls, i.e. PC-3 and the pcDNA3-pooled, suggesting that the expression of p202 may be responsible for the decreased growth rate in PC-3 cells. It is interesting to note that p202-1, which has a modest level of p202 expression ( Figure 1B ), grew at an intermediate rate between the high expressors and the control cell lines, suggesting a p202 dosedependent growth inhibition. Another growth assay, MTT assay (Hansen et al., 1989) , was also performed in these cell lines and the p202-expressing cells also showed a reduced growth characteristics than the control cell lines (data not shown). Since the growth rate is the net result of two competing processes, i.e. cell replication and cell death, it is possible that the reduced growth rates may be caused by the p202-induced anti-cell replication and/or apoptosis in these cells. To test these possibilities, we have measured the percentage of the apoptotic cells in each asynchronized cell population by using Flow Cytometry Analysis. No signi®cant apoptosis could be observed in all these cell lines under the normal growth condition (data not shown), suggesting that apoptosis may not play a signi®cant role in the p202-mediated growth inhibition in PC-3 cells. Since DNA synthesis rate has been used as an indicator for the rate of cell replication (Yu et al., 1993) , we then determined if p202 may inhibit cell growth by reducing the DNA synthesis rate in PC-3 cell. [
3 H]thymidine incorporation assay was employed to measure the DNA synthesis rate in each cell line. Figure 2B shows that the high expressors, p202-2, -3 and -4 exhibited much slower DNA synthesis rate than that of the control cell lines. Again, p202-1 showed an intermediate rate of DNA synthesis. Taken together, the data strongly suggest that the p202-mediated growth retardation in PC-3 cells may be primarily resulted from a reduced rate of cell replication.
The p202 expression can inhibit the anchorageindependent growth of human prostate cancer cells Since IFN-a has been shown to have an anti-tumor activity in human prostate cancer cells (van Moorselaar et al., 1991) , we tested if p202 expression could suppress the transformation phenotype of PC-3 cells, e.g. anchorage-independent growth. Using an in vitro soft-agar colonization assay ( Figure 3A) , we showed that while the control cell lines, PC-3 and pcDNA3-pooled, could readily form colonies in soft agar, the p202-expressors, p202-1, -2, -3 and -4, showed a greatly reduced ability to form colonies in soft agar ( Figure  3B ). This result suggests that the p202 expression could diminish the ability of PC-3 to grow in an anchorageindependent manner. Interestingly, the modest expressor, p202-1, like the high expressors, has lost most of its ability to form colony in soft agar, suggesting that the expression of p202 is more potent in repressing transformation than in inhibiting cell growth.
In this report, we described that the IFN-ainducible protein, p202, not only could inhibit the growth of human hormone-refractory prostate cancer cells by reducing the DNA synthesis rate in the cells but also could abolish the ability of these cells to grow in soft agar. Thus, the p202 expression may be responsible for the loss of transformation phenotype in these prostate cancer cells. The mechanisms by which p202 inhibits cell growth are not yet well de®ned. However, it is conceivable that the p202-mediated inhibition of DNA synthesis (Lembo et al., 1995;  and this study) may be caused by the downregulation of the S-phase genes whose activation depends on the transactivation function of E2Fs. The expression of p202 abolishes E2F function because p202 interacts with the DNA binding domains of E2Fs (Choubey et al., 1996a; Choubey and Gutterman, 1997) , preventing E2Fs from activating the transcription of the S phase genes. How p202 inhibits transformation phenotype such as anchorage-independent growth of prostate cancer cells remains unknown. With the p202-expressing prostate cancer cell lines available, we have begun to investigate the molecular 
Materials and methods

Cell lines and plasmids
Two human prostate cancer cell lines, PC-3 (Kaighn et al., 1979) and DU145 (Stone et al., 1978) , were cultured in DMEM/F12 media supplemented with 10% fetal bovine serum. The plasmids, pcDNA3 (Invitrogen, San Diego, CA, USA) and CMV-p202 (Choubey et al., 1996a) , were transfected into PC-3 and DU145 cells. After 3 weeks of G418 selection (0.5 mg/ml), the drug-resistant colonies were scored by crystal violet staining ( Figure 1A ). Four p202-expressing PC-3 clones, i.e. p202-1, -2, -3 and -4, were identi®ed by using Western blot with a polyclonal antibody against p202 protein (Choubey and Lengyel, 1993) . The G418-resistant colonies from either pcDNA3 or CMV-p202 transfection were pooled as controls.
The growth assays 1. Direct cell counting. Cells growing in logarithmic phase in DMEM/F12 media supplemented with 10% fetal bovine serum were trypsinized, counted, and seeded in 60 mm culture dishes at 50 000 cell per dish. At 24 h intervals the cells were trypsinized and an aliquot was counted on a Coulter Counter ZM (Coulter Corporation, Miami, FL, USA). All counts were done in triplicate. 2. [
3 H]thymidine incorporation assay. This assay was carried out as described previously (Yu et al., 1993) . Every data point was done in quadruplicate.
Soft-agar assay
Aliquots of cells (1610 4 ) were mixed at 378C with 0.5% agarose (Sea Plaque, low gelling temperature, FMC Bioproducts, Rockland, ME, USA) in complete media and gelled at 48C for 15 min over a previously gelled layer of 1% agarose in complete media in six well dishes. After incubation for 3 weeks, 200 ml of 1 mg/ml p-iodonitrotetrazolium violet was added and incubated for an additional 24 h.
